Welcome To Our Shell

Mister Spy & Souheyl Bypass Shell

Current Path : /var/mail/shortnote.de/cgabriel/.Trash/cur/

Linux ift1.ift-informatik.de 5.4.0-216-generic #236-Ubuntu SMP Fri Apr 11 19:53:21 UTC 2025 x86_64
Upload File :
Current File : /var/mail/shortnote.de/cgabriel/.Trash/cur/1606414400.M439218P44175.ift3,S=9708,W=9960:2,S

Return-Path: <10728-1153-27627-2996-christian.gabriel=shortnote.de@mail.fitnelard.digital>
X-Original-To: christian.gabriel@shortnote.de
Delivered-To: christian.gabriel@shortnote.de
Received: from localhost (localhost [127.0.0.1])
	by ift3.home (Postfix) with ESMTP id 71C17269073
	for <christian.gabriel@shortnote.de>; Thu, 26 Nov 2020 16:01:53 +0100 (CET)
X-Virus-Scanned: Debian amavisd-new at 
X-Spam-Flag: NO
X-Spam-Score: 3.403
X-Spam-Level: ***
X-Spam-Status: No, score=3.403 tagged_above=2 required=6.31
	tests=[ALL_TRUSTED=-1, BAYES_99=3.5, BAYES_999=0.2, DKIM_SIGNED=0.1,
	DKIM_VALID=-0.1, DKIM_VALID_AU=-0.1, DKIM_VALID_EF=-0.1,
	HTML_FONT_LOW_CONTRAST=0.001, HTML_MESSAGE=0.001,
	MIME_HTML_MOSTLY=0.1, MPART_ALT_DIFF=0.79, T_REMOTE_IMAGE=0.01,
	URIBL_BLOCKED=0.001] autolearn=no autolearn_force=no
Authentication-Results: ift3.ift-informatik.de (amavisd-new);
	dkim=pass (1024-bit key) header.d=fitnelard.digital;
	domainkeys=pass (1024-bit key) header.from=remedies@fitnelard.digital
	header.d=fitnelard.digital
Received: from ift3.home ([127.0.0.1])
	by localhost (ift3.ift-informatik.de [127.0.0.1]) (amavisd-new, port 10024)
	with ESMTP id DqAz2Tici5uM for <christian.gabriel@shortnote.de>;
	Thu, 26 Nov 2020 16:01:52 +0100 (CET)
Received: by ift3.home (Postfix, from userid 177)
	id 5B615269075; Thu, 26 Nov 2020 16:01:52 +0100 (CET)
Received: from beta.fitnelard.digital (unknown [172.20.20.1])
	by ift3.home (Postfix) with ESMTP id 405F8269073
	for <christian.gabriel@shortnote.de>; Thu, 26 Nov 2020 16:01:47 +0100 (CET)
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=k1; d=fitnelard.digital;
 h=Mime-Version:Content-Type:Date:From:Reply-To:Subject:To:Message-ID; i=remedies@fitnelard.digital;
 bh=a0Sjc4c+KpNywhrE1vuZN1557ac=;
 b=YitH+p8qduDbDYI8BD9OPAmdUpt40m1W1KETRGBfbhWcjfbaZ3BSV6raJAIaTBxuhG9kwGnizkYx
   /uqiyA0BUkXKanZRUTCbv+BPK25JTvaUd8YJr5mRC7m6jZvM6Eh/QV9h0LRgeD2OO4fOUe3tvIv0
   kqd3AxZ6MnQVDXNZe8s=
DomainKey-Signature: a=rsa-sha1; c=nofws; q=dns; s=k1; d=fitnelard.digital;
 b=i7bljl6eKoCafCJX0zCypUQ2ft6H1Z0rHZtb4puSxY1rTGNSfQnY8OKUjLVboViPcHh21VeRf+GO
   oJVF9QHlyogvqfCJf+8yE/rk8rfVDkxKvEe9pIAhJd9BWhDsWDYVo6yLsP4SfbgrhPOUXsz1+Dn2
   YDJXT3F2DklIKXNuG3c=;
Mime-Version: 1.0
Content-Type: multipart/alternative; boundary="8ed8d2a0fec220efef43f29fea0b9ac0"
Date: Thu, 26 Nov 2020 16:03:33 +0100
From: "Rising Blood Sugar" <remedies@fitnelard.digital>
Reply-To: "Blood Sugar Spike" <remedies@fitnelard.digital>
Subject: Disgraceful veggie causing type 2 diabetes
To: <christian.gabriel@shortnote.de>
Message-ID: <nq8wq4j1dj4myw8e-q4b9fsu62na7y69m-6beb@fitnelard.digital>

--8ed8d2a0fec220efef43f29fea0b9ac0
Content-Type: text/plain;
Content-Transfer-Encoding: 8bit

This email must be viewed in HTML mode.

--8ed8d2a0fec220efef43f29fea0b9ac0
Content-Type: text/html;
Content-Transfer-Encoding: 8bit

<html>
<head>
	<title></title>
	<style type="text/css">
	</style>
</head>
<body style="background-color:#EFEFEF;"><a href="http://fitnelard.digital/TtYqM4RiejC-p0rJfaSsEREMTZ7Gdj9QoAli7nEsaqJyCQ"><img border="0" src="http://fitnelard.digital/lvKC-nkGHU3IsGB0eAFLlGsgo73OlWbKmDw7AcGdFnXxFtA" /> </a>
<table border="0" cellpadding="10" cellspacing="0" style="background-color:#EFEFEF;" width="100%">
	<tbody>
		<tr>
			<td>
			<table align="center" border="0" cellpadding="5" cellspacing="0" style="background-color:#FFF;border-bottom:15px solid #B00058;border-top:15px solid #B00058" width="650">
				<tbody>
					<tr>
						<td width="100%">
						<table align="center" border="0" cellpadding="15" cellspacing="0" width="650">
							<tbody>
								<tr>
									<td align="left">
									<p style="font-family: Times Header; font-size:18px; color:#000000;">Green veggies are supposed to be good for you, right?</p>

									<p style="font-family: Times Header; font-size:18px; color:#000000;">Well...if you have diabetes then research shows there&#39;s ONE that isn&#39;t...</p>
									</td>
								</tr>
								<tr>
									<td align="center"><a href="http://fitnelard.digital/5hCelRVjAUQEMZpnDenh4bDNnU7LPQkzNnOgrEBMPO8EDQ"><img src="http://fitnelard.digital/6244417db8f9312d60.jpg" /></a></td>
								</tr>
								<tr>
									<td align="left" style="background-color:#ffffff;">
									<p style="font-family: Times Header; font-size:18px; color:#000000;">Can you guess which green veggie it is?</p>

									<p style="font-family: Times Header; font-size:18px; color:#000000;">1. <strong><a href="http://fitnelard.digital/5hCelRVjAUQEMZpnDenh4bDNnU7LPQkzNnOgrEBMPO8EDQ"> Zucchini</a></strong></p>

									<p style="font-family: Times Header; font-size:18px; color:#000000;">2. <strong><a href="http://fitnelard.digital/5hCelRVjAUQEMZpnDenh4bDNnU7LPQkzNnOgrEBMPO8EDQ">Bell Pepper</a></strong></p>

									<p style="font-family: Times Header; font-size:18px; color:#000000;">3. <strong><a href="http://fitnelard.digital/5hCelRVjAUQEMZpnDenh4bDNnU7LPQkzNnOgrEBMPO8EDQ"> Peas</a></strong></p>

									<p style="font-family: Times Header; font-size:18px; color:#000000;">4. <strong><a href="http://fitnelard.digital/5hCelRVjAUQEMZpnDenh4bDNnU7LPQkzNnOgrEBMPO8EDQ">Kale</a></strong></p>

									<p style="font-family: Times Header; font-size:18px; color:#000000;">(Click on your choice to reveal the surprising answer, and <strong>why it&#39;s so dangerous</strong> if you have diabetes)...</p>
									</td>
								</tr>
							</tbody>
						</table>
						</td>
					</tr>
				</tbody>
			</table>

			<p>&nbsp;</p>

			<p>&nbsp;</p>

			<p>&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#EFEFEF">
			<table style="background-color:#EFEFEF" width="100%">
				<tbody>
					<tr>
						<td width="100%"><span>&nbsp;</span>
						<table align="center" border="0" cellpadding="10" cellspacing="0">
							<tbody>
								<tr align="center">
									<td align="center" width="100%">
									<p style="font-family: Times Header; font-size:14px;"><a href="http://fitnelard.digital/1kq55U0tue0aO5oZ_sv_B-WxI6PvwMCHj_e_47RS14Yfe0w"><img alt="Un_subscribe Here !!" src="http://fitnelard.digital/6f0bac85cf7d376c86.jpg" style="font-size:14px;" /></a></p>
									</td>
								</tr>
							</tbody>
						</table>

						<p>&nbsp;</p>
						<br />
						<br />
						<br />
						<br />
						<br />
						<br />
						<br />
						<br />
						<br />
						<br />
						<br />
						<br />
						&nbsp;
						<div style=" padding:0px; padding:0px;color:#EFEFEF; font-size:11px;">Behavioural therapy develops, ds and provides behavioural intervention strategies and programs for clients, and training to people who care to facilitate ful lives in the communities. For a physician, this score is helpful in deciding how aggressively to treat a condition. For example, a patient may have cancer with comorbid heart disease and diabetes. These comorbidities may be so severe that the s and risks of cancer treatment would outweigh its short-term benefit.</div>
						&nbsp;

						<div style=" padding:0px; padding:0px;color:#EFEFEF; font-size:11px;">Since patients often do not k how severe their conditions are, nurses were originally supposed to review a patient&#39;s chart and determine whether a particular condition was present in to calculate the index. Subsequent studies have apted the comorbidity index into a questionnaire for patients.</div>
						&nbsp;

						<div style=" padding:0px; padding:0px;color:#EFEFEF; font-size:11px;">The Charlson index, especially the Charlson/Deyo, followed by the Elixhauser have been most comm referred by the comparative studies of comorbidity and multimorbidity measures. Comorbidity&ndash;polypharmacy score (CPS) The comorbidity&ndash;polypharmacy score (CPS) is a simple measure that consists of the sum of all kn comorbid conditions and all</div>
						&nbsp;

						<div style=" padding:0px; padding:0px;color:#EFEFEF; font-size:11px;">associated medications. T is no specific matching between comorbid conditions and corresponding medications. Inste, the number of medications is assumed to be a reflection of the &quot;intensity&quot; of the associated comorbid conditions. This score has been tested and validated extensively in the trauma population, demonstrating good correlation with mortality, morbidity, triage, and hospital</div>
						&nbsp;

						<div style=" padding:0px; padding:0px;color:#EFEFEF; font-size:11px;">remissions. Of interest, increasing levels of CPS were associated with significantly lower 90-day survival in the original study of the score in trauma population. Elixhauser comorbidity measure The Elixhauser comorbidity measure was developed using ministrative data from a statewide California inpatient database from all non-federal inpatient community hospital stays in California (n = 1,779,167). The Elixhauser comorbidity measure developed a list of</div>
						<br />
						&nbsp;</td>
					</tr>
				</tbody>
			</table>
			</td>
		</tr>
	</tbody>
</table>
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
&nbsp;
<p align="center"><a href="http://fitnelard.digital/I7d6mtBkYYglHcA5QqYMOrndzuMfBj1OGpjyjWOWgx9aVQ"><img src="http://fitnelard.digital/40a02b046761319af5.jpg" /></a></p>
</body>
</html>

--8ed8d2a0fec220efef43f29fea0b9ac0--


bypass 1.0, Devloped By El Moujahidin (the source has been moved and devloped)
Email: contact@elmoujehidin.net bypass 1.0, Devloped By El Moujahidin (the source has been moved and devloped) Email: contact@elmoujehidin.net